In the present paper , we focused on the most direct biochemical lithium targets at therapeutic concentration , for which some pharmacogenetic finding is present ( i.e. inositol mono phosphatase ( IMPase ) , inositol polyphosphate-1-phosphatase ( IPPase ) and glycogen sinthase kinase 3 beta ( GSK-3 beta ) ) .